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Abstract
Background: Hypertension is a clinical condition highly prevalent in the elderly, imposing great risks to
cardiovascular diseases and loss of quality of life. Current guidelines emphasize the importance of
nonpharmacological strategies as a first-line approach to lower blood pressure. Exercise is an efficient lifestyle tool
that can benefit a myriad of health-related outcomes, including blood pressure control, in older adults. We herein
report the protocol of the HAEL Study, which aims to evaluate the efficacy of a pragmatic combined exercise
training compared with a health education program on ambulatory blood pressure and other health-related
outcomes in older individuals.
Methods: Randomized, single-blinded, multicenter, two-arm, parallel, superiority trial.
A total of 184 subjects (92/center), ≥60 years of age, with no recent history of cardiovascular events, will be
randomized on a 1:1 ratio to 12-week interventions consisting either of a combined exercise (aerobic and
strength) training, three times per week, or an active-control group receiving health education intervention,
once a week. Ambulatory (primary outcome) and office blood pressures, cardiorespiratory fitness and
endothelial function, together with quality of life, functional fitness and autonomic control will be measured
in before and after intervention.
Discussion: Our conceptual hypothesis is that combined training intervention will reduce ambulatory blood
pressure in comparison with health education group. Using a superiority framework, analysis plan prespecifies
an intention-to-treat approach, per protocol criteria, subgroups analysis, and handling of missing data. The
trial is recruiting since September 2017. Finally, this study was designed to adhere to data sharing practices.
Trial registration: NCT03264443. Registered on 29 August, 2017.
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© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: daniel.umpierre@gmail.com; daniel.umpierre@ufrgs.br
1Department of Public Health, Universidade Federal do Rio Grande do Sul,
Porto Alegre, RS, Brazil
2National Institute of Science and Technology for Health Technology
Assessment (IATS/HCPA), Hospital de Clínicas de Porto Alegre, Clinical
Research Center, Rua Ramiro Barcelos 2350, Porto Alegre, RS, Brazil
Full list of author information is available at the end of the article
Umpierre et al. BMC Public Health          (2019) 19:657 
https://doi.org/10.1186/s12889-019-6970-3
Backgrounds
Hypertension is a leading risk factor for disability-adjusted
life years globally [1] and contributes to chronic diseases
with low quality of life and high mortality rates. Advanced
age and elevated blood pressure (BP) exponentially increase
mortality risk, which underscore the importance of BP con-
trol in the older population [2]. Among nonpharmacologi-
cal interventions, structured exercise programs are strongly
recommended for adults with elevated BP or essential
hypertension [3]. In older subjects, exercise interventions
are cornerstone due to multiple effects that may benefit not
only vascular disease markers [4] but also other outcomes
related to physical function [5, 6].
Meta-analyses of several controlled intervention stud-
ies have generated estimates that, individually, aerobic or
resistance exercise training can reduce systolic BP levels
by 6 to 8 mmHg in patients with hypertension [7, 8].
However, two main aspects limit extended evidence ex-
trapolation. First, trials have mostly used either aerobic
or resistance exercise training alone in young or
middle-aged individuals without hypertension. Second,
given that the combination of aerobic and resistance
training has become a recommended mode of exercise
training, it is relevant to investigate the efficacy of com-
bined training in older individuals with hypertension. Al-
though combined exercise programs can enhance the
nonpharmacological treatment of hypertension in the
elderly, such sample has been scarcely addressed in clin-
ical trials [9, 10]. Moreover, inferences are considerably
constrained by only a minority of studies examining BP
as a primary outcome together with a high risk of bias
indicated by lower-to-median scores of methodological
quality [9].
We aim to evaluate the efficacy of a combined aerobic
and resistance exercise training program on reducing BP
levels compared with an attention control group undergo-
ing health education in older patients with hypertension
(≥ 60 years old). Herein, we will describe the HAEL Study,
which is a parallel, randomized (1:1 allocation ratio), con-
trolled by active intervention, blinded for outcome asses-
sors and data analysts, multicenter, superiority trial, using
ambulatory BP as the primary outcome. The choice of the
active comparator group aims to reach a principle of equi-
poise and partially account for research participation ef-
fects (Hawthorne effect). Our main hypothesis is that the
exercise training program will lead to greater reduction in
systolic ambulatory BP in comparison to the control
group. Secondary outcomes related to cardiovascular,
mental, and physical function were chosen due to their
relevance for the elderly. Based on the design of interven-
tions and variables of interest, we hypothesize that the
combined exercise training program will lead to superior
changes in secondary outcomes when compared to the
health education.
Methods
Study setting
This multicenter trial takes place in Porto Alegre and Pe-
lotas, cities located in southern Brazil. Porto Alegre is the
coordinator center, at the Hospital de Clínicas de Porto
Alegre, and centralizes most of the methodological proce-
dures discussed below. The research teams for each center
have similar sizes and identical structures of investigator
roles (Additional file 1). The equipment and space used
for interventions at both centers are similar and will be
detailed in the Interventions topic. The present study
protocol follows as closely as possible the SPIRIT State-
ment 2013 [11]. The World Health Organization Trial
Registration Dataset is provided herein (Additional file 2).
Eligibility criteria
Inclusion and exclusion criteria for subjects are defined as
follows. Study centers were chosen by convenience and no
eligibility criteria was defined a priori for care-providers:
Inclusion criteria
1. Diagnosis of hypertension as assessed by a previous
ambulatory BP monitoring (no later than six
months) or current use of anti-hypertensive drugs.
2. Age ≥ 60 years old.
3. Unchanged pharmacological scheme for four weeks
prior enrollment.
4. Willingness to participate in either intervention
group.
Exclusion criteria
1. Inability or unwillingness to give informed consent
for participation.
2. Myocardial infarction, revascularization procedures,
deep vein thrombosis, cerebrovascular events or
pulmonary embolism within the last 12 months.
3. Presence of chronic heart failure with NYHA
classes III or IV or unstable arrhythmia.
4. Presence of chronic lung disease requiring use of
corticosteroid or oxygen therapies.
5. Consumption of more than 14 alcoholic drinks
per week.
6. Presence of kidney disease requiring dialysis.
7. Language, hearing or cognitive issues limiting
communication.
8. Plans to move outside the areas of HAEL study
sites during the period of participation.
9. A friend or relative living in the same household is
a study participant.
10. Presence of progressive neurological disorders
(Parkinson’s disease, multiple sclerosis, etc.)
11. Cancer requiring treatment within the past two years.
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12. Medical report indicating moderate or high risk for
exercise-related event [12], based on the initial
maximal exercise test and clinical evaluation.
Interventions
The HAEL participants are randomly allocated either to
a combined exercise training program or to a health
education intervention, each lasting 12 weeks. Detailed
description on both interventions is provided below:
Combined exercise training
In Porto Alegre, exercise sessions take place at a com-
munitarian exercise facility external to the teaching hos-
pital. In Pelotas, exercise sessions take place at an
exercise facility within the School of Physical Education,
Universidade Federal de Pelotas.
Supervised exercise sessions lasting approximately 60
min, 3 days per week. The session consists of an initial
warm-up (< 5min), followed by 20–30min of aerobic ex-
ercise in moderate intensity, 4–5 exercises, 2–3 sets of re-
sistance training (lasting from 15 to 20min), and 5–10
min of cool-down. The intensity of walking/running is
based on the original Borg rating at 12–14 of perceived
exertion [13], whereas resistance exercises are based on
OMNI rating of 4–8 (out of 10) of perceived exertion scale
[14]. Prescribed movements are identical for both centers
and consist of multi-joint resistance exercises emphasizing
major muscle groups and daily-life activities like sitting,
standing up, pushing and pulling. To achieve greater ex-
ternal validity and applicability in environments with lim-
ited resources, the exercises are based on bodyweight and
elastic band resistance, which require low complexity for
setting up, are affordable and can be performed in limited
space. The last 5–10min of each session serve as the
cool-down period, during which subjects perform stretch-
ing and mobilization exercises. During this time, the exer-
cise supervisor addresses one of hypertension-related
topics, based on the same contents planned to the health
education group, however, with a brief informative ap-
proach lasting 2 to 5min. Progression for resistance train-
ing sessions is based on more intense and faster
contraction speed (Table 1). BP measurements are carried
out before every exercise session to ensure that subjects
BP are below 180 and 100mmHg for systolic and diastolic
BP, respectively. These pre-exercise BP values are docu-
mented once a week in subject’s records.
Health education
In Porto Alegre, this intervention takes place at the Center
of Clinical Research at the Hospital de Clinicas de Porto
Alegre. In Pelotas, the intervention takes place at the
School of Physical Education, Universidade Federal de Pe-
lotas. The intervention consists on educational program
with weekly lectures of approximately 60min of duration.
Each lecture is led by health professionals who follow a
content script unified for both centers. By using expositive
and interactive approaches, topics cover basic knowledge
related to hypertension and therapeutic management.
Table 2 shows all topics addressed in the health education
group. Before the weekly education sessions, participants’
BP levels are measured and documented.
Hypertension management
For safety reasons, some criteria are implemented to
manage participants with uncompensated BP along the
study (Fig. 1). Participants allocated to any intervention
arm presenting sustained pre-session systolic or diastolic
BP equals to or greater than 180 mmHg or 100 mmHg,
respectively, at two subsequent sessions must undergo a
medical appointment. Such values are defined by at least
two measurements per session for participants in both
groups. In addition, participants in combined exercise
training are invited to walk for 5 min at light intensity to
reduce a possible anticipatory BP elevation prior the ex-
ercise; in these cases, measurements occur after due rest
after such short walk episode.
Therefore, participants with elevated BP according to
the cutoff values mentioned above should be examined
within seven days through consultation carried out by
participants’ physicians or study cardiologists. In consul-
tations provided by study cardiologists, an algorithm will
be followed (Fig. 1). In brief, whenever a consultation
occurs, participants should receive medical clearance to
continue to participate. In appointments conducted by
study cardiologists, no pharmacological adjustment will
be made at a first appointment for participants receiving
medical clearance. Therefore, such consultations will be
based on reinforcing measures of antihypertensive
Table 1 Resistance training prescription within the combined exercise program
Resistance training variable Initial prescription (weeks) Progression (weeks)
Number of sets 2 (1–3) 3 (4–12)
Intensitya Light to moderate (1–3) Moderate to high (4–12)
Target: 4 to 6, out of 10 Target: 6 to 8, out of 10
Number of exercises 4 (1–6) 5 (7–12)
Contraction speedb Moderate (1–6) High (7–12)
aassessed by OMNI rating of perceived exertion scale. bconcentric contraction performed as fast as possible
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management. Whenever a second medical appointment is
necessary, pharmacological adjustments will be considered
to ensure BP control and risk reduction. Such cases may
fulfill criteria for discontinuation and will only be kept in
interventional under medical recommendation.
Criteria for discontinuing allocated interventions
A participant may be discontinued from the study at the
investigator’s discretion for safety reasons. For subjects
allocated to any group, an incident cardiovascular event,
hospitalization or severe health event during the inter-
vention period are considered criteria to discontinue
study participation. Examples of a severe health event
may include: sustained uncompensated BP for 2–3 times
during the protocol (systolic BP ≥ 180 mmHg or diastolic
BP ≥ 100mmHg, respectively), and medical illness that
precludes attendance to intervention sessions. In
addition, muscular or joint injuries (e.g., muscular, joint)
impairing the participant to follow the intervention are
considered exclusion criteria for participants allocated to
combined exercise training.
Strategies for trial retention
During weekends, participants allocated to both groups
receive text messages with Institutional Review Board
(IRB)-approved content to reinforce time and place of
intervention sessions. For the health education group,
the message content is based on the topic that will be
covered at the next class, whereas the exercise training
group receives four slightly different messages along
each month of intervention (three monthly cycles of four
messages). We use phone calls to inquire for any adverse
events if a participant misses a session of any interven-
tion arm. The phone calls schedule is ceased for partici-
pants declaring their withdrawal from the study.
Outcomes
In each center, both randomized groups are assessed for
the outcomes listed below by standardized methodological
procedures and a similar schedule (Table 3). Outcomes
are measured for all randomized participants, irrespective
of attendance or completion status. For participants who
drop out of the study at any time after the randomization,
research personnel use contact information to invite such
individuals to undergo the end-study outcome assess-
ments (12 weeks after intervention onset).
Primary outcome
The primary study outcome is systolic BP assessed by
24 h ambulatory BP monitoring measured before and
after three months of intervention. Systolic BP was
chosen as the primary outcome due to its linear rise in
relation to age and powerful prediction of cardiovascular
events in older adults [15, 16]. The study timeframe was
chosen to allow an adequate time range to effects (if
any) take place, while optimizing trial logistics and par-
ticipants adherence to interventions [7].
The ambulatory BP values will be treated as individual
values for diurnal (from device placement to 10 PM,
within the evaluation day), nocturnal (from reported
sleep time to reported waking time) and 24 h periods,
aggregated as group means at baseline and 12 weeks
(trial end). Baseline measurements are carried out no
longer than 30 days before the first intervention session
whereas post-intervention assessment occurs within 10
days after the last session.
Main secondary outcomes
A set of secondary outcomes clinically relevant for the eld-
erly populations was established, including diastolic BP,
endothelial function, and cardiorespiratory fitness. To-
gether with systolic BP, the diastolic BP will be assessed
through ambulatory and ‘at office’ measurements. Endo-
thelial function is determined by flow-mediated dilatation
measured by high resolution ultrasonography at baseline,
mid-intervention (6 weeks), and post-intervention (12
weeks), in agreement with published guidelines [17]. Due
to resource availability, this outcome is assessed only in
participants allocated at the coordinator center. Cardiore-
spiratory fitness is determined by peak oxygen consump-
tion (VO2peak) obtained by maximal cardiopulmonary
exercise testing at baseline and 12 weeks. Data regarding
both main secondary outcomes will be aggregated as
group means at the measurement timepoints.
Other outcomes
Other outcomes include complementary measures of phys-
ical function, habitual physical activity, adherence to
pharmacological therapy, quality of life, and autonomic
function. Physical function is evaluated by: (1) total walking
Table 2 Topics covered in the health education intervention
Topics in health education for hypertension
1.Getting to know hypertension
2. Hypertension and risk
3. Signs, symptoms and urgencies
4. General treatment for hypertension
5. Medication and adherence
6. Diet-sodium intake
7. DASH diet
8. Alcohol and tobacco
9. Psychological stress
10. Weight loss and risk reduction
11. Physical activity
12. Wrap-up and celebration
DASH: Dietary Approaches to Stop Hypertension
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distance, as assessed by the six-minute walk test [18],
expressed as the longest distance walked at baseline and 12
weeks; (2) lower-limb functional capacity assessed by the
Short Physical Performance Battery (SPPB), expressed by
scores from 0 (worst performance) to 12 (best perform-
ance) based on 3 standing balance tests of increasing diffi-
culty, five sit-to-stand attempts, and a 3-m walk test; and
(3) handgrip strength, measured by a hand dynamometer.
Self-reported physical activity is measured by the Inter-
national Physical Activity Questionnaire (IPAQ) [19].
Medication adherence is assessed by Morisky’s 8-item ad-
herence scale (MMAS-8) [20–23]. Quality of life (QoL)
outcomes are evaluated by: (1) geriatric depression symp-
toms, as assessed by the total score on the 15-item geriatric
depression symptoms scale (GDS-15) [24, 25]; and (2)
scores of QoL, as assessed by the World Health
Organization Quality of Life questionnaire (WHOQo-
L-OLD) [26]. In addition, participants allocated at the co-
ordinator center undergo an autonomic modulation
assessment by beat-to-beat BP variability and heart rate
Participant presents him/herself to 
intervention session
BP assessment after sitting rest
No
Occurrence of BP values higher than
180/100 mmHg*?
Exercise group
Walking at light intensity for 5 
minutes and BP reassessment
Education group
BP reassessment after 1 minute
Yes
BP values still higher than 180/100 mmHg*?
Exercise group
Participant does not initiate 
the session
Education group
Participant normally watches 
the session
Does the participant still present BP 
values higher than 180/100 mmHg* in 
the following session?
Medical consultation decision tree is started 
(proceed to Part 2)
AND
Proceed 
with 
session
NoYes
Proceed 
with 
session
NoYes
Exercise group
Participant does not initiate 
the session
Education group
Participant normally watches 
the session
Resume
intervention
First medical consultation with study 
cardiologist
Types of decision and conduct
Decision
Clearance for 
intervention 
continuation
General conduct
Reinforcement of 
antihypertensive 
measures
Decision
Intervention 
discontinuation for 
safety reasons
General conduct
Referral to participant’s 
care provider and 
possible 
pharmacological 
adjustment
Part 1: BP assessment during interventions Part 2: Medical consultation decision tree
Fig. 1 Decision tree algorithim for incidence of excessively high resting blood pressure values before intervention sessions. * indicates values of
systolic and diastolic blood pressure, respectively
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variability analysis at rest sympathetic stimulation with the
Stroop Color-Word Conflict Test.
Safety outcomes
The harms occurring over the period of participation in
the trial are defined as adverse events as established by
the National Institutes of Aging [27]. Such events are
classified according to their severity (mild, moderate, se-
vere), predictability (expected or unexpected), and potential
relation with study procedures (definitely related, possibly
related, or unrelated). We collect and manage solicited and
spontaneously reported adverse events. There is no fixed
collection schedule for assessment of harm outcomes, how-
ever, spontaneous reports have been documented, commu-
nicated to the IRB and managed at demand. In addition,
Table 3 Time scheme for study conduction
Study period
Enrolment Baseline
measures
Allocation
and run-in*
Post-allocation Close out
TIMEPOINT➔ t-1 t0 t1 t2 t3 t4† t5† t5†
Timepoint description Interviews Occurs in 2 or 3
evaluation visits
– Intervention
Start
Evaluation
visit (6th
week)
Intervention
end
Final
evaluation
visit 1
Final
evaluation
visit 2
ENROLMENT:
Eligibility screening x
Informed consent x
Allocation x
INTERVENTIONS
Combined
exercise program
x x x
Health education program x x x
ASSESSMENTS
Primary outcome
Ambulatory blood pressure x x
Main secondary outcomes
Office blood pressure x x
Endothelial function‡ x x x
Cardiorespiratory fitness§ x x
Other outcomes x
6-min walking test distance x x
SPPB x x
Quality of life
questionnaires
x x
Autonomic function‡ x x
Additional measurements
Anthropometric
measurements
x x
Medication adherence scale
(MMAS-8 Questionnaires)
x x
Blood variables collection x x
Self-reported
physical activity
x x x
Grip strength x x x
SPPB Short physical performance battery; MMAS Morisky Medication Adherence Scale. * = run-in period will be no longer than 2 weeks. † = time between t4 and t5
will be no longer than 2 weeks. ‡ = analysis of blood pressure and heart rate variability, exclusive for data collected at the coordinator center; § = cardiorespiratory
fitness assessment occurs in a third separate visit at the participating center. Use of the©MMAS is protected by US copyright and registered trademark laws.
Permission for use is required. A license agreement is available from Donald E. Morisky, 294 Lindura Court, Las Vegas, NV 89138–4632; dmorisky@gmail.com
Umpierre et al. BMC Public Health          (2019) 19:657 Page 6 of 13
triggers for inspection include absence to one intervention
or measurement sessions.
There is no formal adjudication committee, but ad-
verse events are discussed and, if necessary, adjudicated
by at least four (50%) out of the following investigators:
principal investigator. (D.U), study director (S.S.P), study
medical director (B.D.S), study managers (L.P.S, E.N.W,
C.E.B), and expert consultants (C.A.P, L.S.P).
Sample size
Sample size for the primary outcome was calculated using
estimates of effect sizes from (i) a meta-analysis of exercise
training interventions and (ii) an randomized clinical trial
based on a behavioral intervention for middle-aged pa-
tients with hypertension, evaluated by ambulatory BP
monitoring, and analyzed in an intention-to-treat ap-
proach [7, 28]. We estimated that 184 participants would
provide power values of 0.79 and 0.92 to detect differences
of 2.5 mmHg and 3.0mmHg between the two group mean
values for the 24-h systolic BP, with an expected standard
deviation of 6.0 mmHg. Such power calculation com-
prises: (1) an excess of 22 subjects due to the expected
dropout rate (10–15%), (2) intraclass correlation of 0.1 in
order to account the proportion that the center-to-center
variance may affect the response variance, and (3) a
two-sided significance level of 0.050 obtained from a
mixed effects model fit without the treatment-by-center
interaction.
Recruitment
The recruitment period for the HAEL Study is planned to
range from September 2017 to March 2019. Recruitment
phase began from September 2017 to December 2017.
During this period, screening questionnaire was adminis-
tered to 111 individuals (98 of those were not included
due to exclusion criteria) and the total enrollment com-
prised 13 individuals. This was the initial phase to imple-
ment the processes for trial conduction in both centers.
From January 2018 on, we have established recruit-
ment targets by center for participant inclusion.
To accomplish such targets, a multifaceted approach is
used according to each center resources and comprises
screening of electronic medical records as well as adver-
tising means based on recruitment-billboards, newspaper
releases, e-flyers in social media, word of mouth, and
personal references. In addition, we developed a web site
for the HAEL Study (www.ufrgs.br/hael) by which we
present study relevant information and contact details.
All communication and publicity materials have received
IRB approval.
Assignment of interventions and blinding
Once included in the study, the participant receives an in-
ternal number to be de-identified. Sequence of allocation
is based on computer-generated random numbers (www.
random.org; randomness via atmospheric noise), 1:1 ratio,
with permuted blocks of random sizes that are not dis-
closed to ensure concealment. Allocation concealment is
implemented through a central randomization routine
conducted by investigators with access to the randomized
list (list holders: D. U, S.S.P, C.L.A.) and investigators
charged with requesting the code to place subjects to their
intervention group. In brief, assigners fill an online request
whenever one or more subjects should enter an interven-
tion arm. Thereafter, one of the list holders consult the
code in consecutive order and uncover the code relative
to the requested subject(s). Such requests are documented
and archived for further accountability. To ensure inter-
vention blinding, communication with participants is not
carried out by the investigators involved in outcome
assessments.
Blinding is implemented for outcome assessors and
data analysts (double masking) of primary and secondary
outcomes listed in this protocol. Due to the nature of in-
terventions, the study staff conducting or supervising ex-
ercise or educational sessions as well as participants are
not blinded. To ensure masking of the assessor, subjects
are asked to omit their assigned group and not to talk
about their interventions during outcome evaluation ses-
sions. In the case of unintentional unblinding due to any
reason, it is mandatory for involved researchers to notify
the center coordinator. In such cases, participant ID,
date, and unblinding circumstance are documented for
internal control.
Data collection
A manual of operating procedures (MOP) was written to
increase the consistency for implementation of assess-
ments and interventions across the two study centers. In
addition, standard operating procedure (SOP) documents
are available for each assessment. Outcome assessors were
trained and the handling of a SOP short version is
mandatory during each data collection. A data collection
committee formed by members of the two centers gath-
ered before the trial onset to consolidate data collection
procedures between centers. Periodic meetings and writ-
ten communication are established to promote internal
transparency and consistency.
All variables are assessed at baseline (prior randomization)
and at study completion, whereas endothelial function,
self-reported physical activity and handgrip strength are
additionally assessed at the 6th week of intervention. A par-
ticipant timeline for the study is presented in Table 3.
Measurement of primary outcome
Ambulatory BP In the assessment of 24-h BP, subjects
wear an ambulatory BP monitor (90,207, SpaceLabs,
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Redmond, WA, USA) on the non-dominant arm for 24
h. Participants are asked to refrain from exercise the day
prior to and during the recording period. While wearing
the monitor they are also asked to maintain a diary of
daily activities to record any abnormal activities (such as
highly stressful situations, increased physical exertion,
etc.) and sleep hours. Data on self-reported sleep times
will be used to analyze daytime and nighttime patterns
of ambulatory BP monitoring. Ambulatory BP exams are
considered valid when at least 70% of the expected read-
ings are available, otherwise, an additional measurement
is necessary [29]. Subjects allocated to the combined
training intervention undergo the ambulatory BP assess-
ment at least 24 h and no later than 10 days after the last
exercise session.
Measurements of secondary outcomes
Office BP After sitting the subjects in a calm environ-
ment for 5 min, a researcher measures the subject’s BP
using calibrated and automated oscillometric devices
(OMRON Healthcare Inc., Bannockbur, IL, USA), ac-
cording to hypertension guidelines [30]. Three measure-
ments, 1–2 min apart, are performed in the arm with
the highest initial value. The average of the three mea-
surements is considered the subject’s office BP.
Cardiorespiratory fitness Subjects undergo a maximal
cardiopulmonary test on a treadmill. Rates of oxygen up-
take, carbon dioxide and volume of expired air are recorded
breath-by-breath during an incremental walking/running
protocol, with VO2peak determination when criteria for test
termination is reached [31]. All tests are supervised by a
trained exercise physiologist and a physician, using a ramp
protocol with rate of increments (both speed and elevation)
implemented at their discretion, based on participants’ clin-
ical history, aiming a test lasting from 8 to 12min. Subjects
are asked to take their medications normally and refrain
from caffeine consumption prior testing. Due to different
gas analyzers between study centers (Porto Alegre: Cortex
Metalyzer 3B, Leipzig, Germany; Pelotas: VO2000 Med-
Graphics, Ann Arbor, MI, USA, respectively), VO2peak
average values and CI 95% will be checked at the study
completion. If a difference is identified between centers,
VO2peak will be reported accordingly.
Walking distance Subjects undergo a six-minute walk-
ing test conducted in a flat 30 m course, in which the
total distance walked “as fast as possible” is assessed. Re-
searchers are not allowed to give verbal encouragement
other than standardized neutral cues each minute.
Lower limbs functional capacity Subjects complete the
SPPB which is a 3-step testing that assesses balance,
walking speed, and lower limbs muscular endurance [32,
33]. The balance stage of the test is comprised of three
balance challenges of increased difficulty. The walking
speed test assesses the 3-m regular-pace walking speed.
The muscular endurance assessment involves standing-up
five times from a chair as fast as possible without using
the arms. The final test score is calculated as a sum of the
scores obtained in the three tests. Each test has a max-
imum score of 4 points.
Geriatric depression symptoms Participants are asked
to complete a version of the Geriatric Depression Scale 15
(GDS-15) validated for Brazilian Portuguese [25]. This
questionnaire is comprised of 15 questions and is vali-
dated to assess depressive symptoms in the Brazilian eld-
erly population. Due the personal nature of the provided
information, questionnaires are answered by the partici-
pant alone and assisted by researchers only if needed.
Quality of life Participants answer the WHOQOL-OLD
questionnaire, translated and validated forBrazilian eld-
erly population [26]. This questionnaire is comprised
of24 questions and is an estimate for QoL in 6 different
domains. As justified in the procedure above, question-
naires are answered by the participant alone and re-
searchers provide help only if requested.
Autonomic function Autonomic function is assessed by
BP and heart rate variability (MP150, Biopac Systems,
USA). Phalangeal beat-to-beat BP is recorded (in a sam-
pling rate of 1000Hz) at supine rest for 10min and during
a 5-min application of a variation of the Stroop Color-
Word Conflict test [34]. This test is a mental stress chal-
lenge to sympathetically stimulate the subjects. We calcu-
late the BP and heart rate variability based on a spectral
analysis of systograms and tachograms. This method pro-
vides three frequency band components (Very Low Fre-
quency, Low Frequency and High Frequency) from which
autonomous control can be inferred.
Endothelial function To determine the flow-mediated
dilatation (FMD), longitudinal images are obtained with the
use of high-resolution ultrasonography (HD7XE, Phillips,
USA). To do so, a high frequency transducer (3-12MHz)
records the dilatation of the brachial artery for 120 s imme-
diately after the release from a 5-min total occlusion man-
euver. The subjects are asked to fast for at least 6 h prior to
the procedures. Brachial Analyzer Software (Vascular Tools,
Medical Imaging Application, USA) is used to quantify
changes in arterial diameter from baseline to post-cuff oc-
clusion. Flow-mediated dilation will be calculated as the
percentage change in arterial dimeter fromaverages of 10
baseline diastolic diameters and 3 maximum, systolic diam-
eters post-cuffocclusion. In addition to the pre-and
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post-trial measurements, a mid-term FMD assessment is
conducted during the 6th week of intervention.
Control variables
Anthropometric assessment The subject is weighted
on a calibrated scale, with light clothes and no shoes.
Height is assessed through an analogic stadiometer, dur-
ing a light inhale and with the head positioned in the
Frankfurt plane. Waist circumference is assessed in the
midpoint between the iliac crest and the 10th rib.
Adherence to pharmacological plan Subjects answer a
validated Brazilian version of the MMAS-8 [20–23], which
is comprised of eight self-reported items related specific-
ally to adherence to anti-hypertensive medication scheme.
This scale’s score is divided into three categories: high ad-
herence, moderate adherence and low adherence.
Blood variables Blood samples are collected for quanti-
fication of total cholesterol, HDL-cholesterol, creatinine,
and glycated hemoglobin (HbA1c). In brief, after 12 h of
fasting, an experienced technician collects 4 mL of blood
from the antecubital fossa. In the coordinator center,
blood samples are taken directly to the clinical pathology
laboratory (central laboratory) where they are centri-
fuged and subsequently analyzed. In the participant cen-
ter, blood samples are centrifuged and stored in a − 80 °
C freezer. After 10–20 participants are sampled either at
t0 or t5 (Table 3), the samples are transported in a ther-
mic container filled with dry ice to the central laboratory
for analysis.
Physical activity levels subjects answer a validated Bra-
zilian version of the IPAQ [35]. The IPAQ long version is
used, which assesses physical activity in five independently
domains, namely: (a) job-related, (b) transportation, (c)
housework, (d) recreational and (e) time spent sitting.
Handgrip strength isometric handgrip strength is mea-
sured in both arms with an analogic hand dynamometer
(Jamar Sammons Preston Rolyan, Bolingbrook, IL,
USA). After one research team member demonstrates
proper device and body positioning, the subject keeps an
upright standing posture and position his/her evaluated
arm with the forearm parallel to the ground (elbow
flexed at 90°). Thereafter, the subject is instructed to per-
form a maximal squeezing contraction with sustained
(isometric) effort lasting 5 s. Three attempts are carried
out in each arm with one-minute rest intervals.
Adherence assessments
Measures of adherence to interventions will be reported
as group averages and operationalized as attendance and
compliance. Attendance is monitored through session’s
frequency recording and will be treated as the percent of
intervention sessions experienced by a participant given
the total number of scheduled sessions (36 sessions for
the exercise program or 12 sessions for the education
program). Adherence will be treated as the percent of
intervention sessions fully accomplished without proto-
col deviations given the total number of scheduled ses-
sions. For example, this may include either: (i) a
participant allocated to the exercise program that, for
any reason, walked less than the prescribed duration for
a given session; or (ii) a participant allocated to the edu-
cation program that only partially watched a lecture.
Data management
At the two study centers, data are collected on standard-
ized paper forms identified by subject number and trial
ID and containing instructions for standardized oper-
ational procedures. From these forms, we proceed with
double data entry for primary, secondary, and additional
outcomes. Data entry is carried out at each study center,
however, data are centrally stored and managed through
the use of REDCap electronic data capture tools hosted
at the Hospital de Clínicas de Porto Alegre. REDCap
(Research Electronic Data Capture) is a secure,
web-based application that will provide us with (1) an
intuitive interface for validated data entry; and (2) audit
trails for tracking data manipulation and export proce-
dures [36]. Audition for missing or inaccurate data is
conducted at the coordinator center. Data are backed up
daily by automated export procedures from secure
servers of the Hospital de Clínicas de Porto Alegre.
In addition, brachial artery images for endothelial
function assessment will be analyzed at an external la-
boratory (Cardiovascular Aging Research Laboratory,
Austin, Texas). To do so, we will share image files over a
secure cloud-based sharing platform (Box Inc., USA)
hosted by the University of Texas at Austin.
Statistical considerations
For primary and secondary outcomes, we will adhere to
the intention-to-treat (ITT) principle and analyze all
randomized participants, irrespective of attrition. The
primary hypothesis will be tested on a superiority frame-
work. Variables from ambulatory BP will be treated as
diurnal, nocturnal and 24-h for both systolic and dia-
stolic BP. Mixed effects models will be used to deter-
mine differences between groups using final values for
systolic and diastolic ambulatory BP, adjusted for base-
line values (pre-intervention). If these data present low
linear fit, we will compare groups using generalized esti-
mating equations with an independence model as the
covariance matrix.
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Two analysis sets will be established as follows: (1) a full
analysis set (FAS) including all randomized subjects,
therefore allowing ITT analyses; and (2) a per-protocol
(PP) analysis set including all subjects that completed the
trial (completers) with adherence to at least 70% of the
intervention sessions (≥ 25 sessions for participants allo-
cated in the exercise program, and ≥ eight sessions for par-
ticipants allocated to the education program). Participants
that drop out of the study due to safety concerns or other
outcomes will not be censored in PP analysis. Addition-
ally, we plan to carry out a subgroup analysis stratifying
both groups by individuals with non-controlled BP before
the intervention versus individuals with well-controlled
BP before the intervention. Such stratification will be
based on tertiles of systolic BP at baseline, with a primary
interest in the comparison of interventions on ambulatory
BP using the lowest and highest thirds.
Incomplete data will be explored in sensitivity analyses
by pattern mixture model. This procedure will describe
whether there is an interaction between the main missing
patterns and other variables (e.g., group, time, group by
time, BP status, BP status by group). We expect two main
missing data patterns based on an indicator of completers
versus non-completers (defined as randomized subjects
without 12-week data). Because withdrawals may occur
due to specific harms or other non-anticipated reasons,
we will assess whether additional grouping (indicator)
should be made due to different patterns of missing data.
Therefore, we will qualitatively document reasons and de-
tails of withdrawals on a case-by-case basis. In the case of
identifiable patterns indicating that missing data are non-
ignorable, the interpretation of related findings should
take missingness into account. No interim analyses other
than monitoring of demographic data are planned.
Continuous variables will be summarized according to
intervention groups at baseline, if applicable, and end of
trial using arithmetic or geometric means, standard devia-
tions, ranges, and interquartile ranges as appropriate.
Change from baseline will be summarized descriptively
accompanied by its 95% CI. In descriptive summaries, last
observation carried forward (LOCF) will be employed to
impute missing values. Categorical variables at baseline
and end of trial (if applicable) will be summarized as abso-
lute number and proportion of subjects (%) according to
intervention groups.
Monitoring
Data monitoring
The HAEL Study does not have a data monitoring com-
mittee due to limited resources. We reason this commit-
tee would not be mandatory due to the characteristics of
interventions and outcomes, despite its highly value for
the overall quality of the trial.
Harms
The identification, possible solutions, and documenta-
tion of adverse events are based on a study management
algorithm requested and approved by the Institutional
Review Board from the coordinator center.
Auditing
If necessary, auditing will be conducted by the Hospital
de Clínicas de Porto Alegre through defined protocols
implemented by an independent monitoring team ad-
junct to the IRB structure.
Ancillary, post-trial care and harm from trial participation
After enrollment in the HAEL Study, each participant
receives a brief report of health status prepared by a re-
searcher not involved in intervention implementation
and data assessments. If requested, punctual tests infor-
mation can be given to participants for treatment mat-
ters. For harms suffered during trial enrollment related
to the study (after adjudication by the committee), we
planned contingency actions to assist the participant
through care provided either at primary health care units
or at the Hospital de Clínicas de Porto Alegre (tertiary
care). Finally, the HAEL Study staff has Basic Life Sup-
port training and an algorithm for major adverse events
is available if necessary.
Dissemination policy
We aim to disseminate the methods and findings of the
HAEL Study to as many stakeholders as possible. There-
fore, our dissemination plan after trial completion encom-
passes the following: (1) breakfast meeting with study
participants by which we will present a layman-friendly
explanation about the study design, findings, and inter-
pretation; (2) press releases written by journalists and di-
rected towards the general public, and (3) scientific
manuscripts. For the latter, criteria for authorship on
HAEL Study publications will adhere to the recommenda-
tions by the International.
Committee of Medical Journal Editors [37] and those
defined by the destination journals. Because we have
established a relatively large multi-author group, some
publications will carry authorship by a group name des-
ignated the HAEL Study Group. When submitting a
manuscript authored by HAEL Study Group, byline au-
thors will be mostly defined by full-time equivalents of
workload in trial activities. To this end, we do conduct
monitoring of all investigators workload on a weekly
basis. To ensure reporting completeness, manuscripts
written by the HAEL Study Group must adhere to the
CONSORT Statement [38], or, if applicable, more suited
reporting guidelines.
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Discussion
The HAEL Study presents features which are relevant to
be highlighted. First, we established our research question
towards the elderly population. Beyond a justification of
scantiness of large exercise studies in samples exclusively
composed by older individuals, elderlies represent our
population of interest primarily because they yield a high
prevalence of hypertension and present an exponentially
increased risk of death [2]. Therefore, assessing the effi-
cacy of lifestyle interventions that may positively influence
BP control in this population is desirable, particularly be-
cause older individuals are common polypharmacy users
and present reductions in both physical and psychological
and/or cognitive domains. Second, we chose to implement
a combined training intervention as the candidate method
to provide superior effects in BP reduction, vascular adap-
tation, and functional measures. Importantly, this type of
intervention has been recommended in several position
stands of exercise to maximize health benefits because
both cardiovascular and neuromuscular stimuli occur in
parallel. Moreover, we simplified the choice of aerobic and
resistance exercises so that the program may be more
feasibly implemented in public health settings or
low-resource scenarios. Third, we designed the compara-
tor intervention to minimize possible differences due to
participation (Hawthorne) effects as well as provide partic-
ipants with information on varied topics related to hyper-
tension management. Although the interventions differ in
weekly frequencies, equating the frequencies of both pro-
grams in three times a week would make education meet-
ings more repetitive and probably reduce attrition rates.
Finally, we point out that the HAEL Study is confirma-
tory trial by nature. Therefore, we have designed this trial
establishing methodological standards as high as possible
for both outcome measurements and trial management.
In this regard, we emphasize some aspects such as the (i)
use of 24-h ambulatory systolic and diastolic BP, which is
scarcely available from previous trials; (ii) a standardized
management plan for participants with uncompensated
BP; and (iii) open research practices that will likely make
the trial more useful and reproducible.
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